depression cannabidiol - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 4993

<< First< Prev

Page of 250

Next >Last >>

Select item 76996131.

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

María S. García-Gutiérrez, Francisco Navarrete, Ani Gasparyan, Amaya Austrich-Olivares, Francisco Sala, Jorge Manzanares

Biomolecules. 2020 Nov; 10(11): 1575. Published online 2020 Nov 19. doi: 10.3390/biom10111575

PMCID:: PMC7699613

Article PubReader PDF–807K Cite

Select item 73854252.

Cannabidiol as a Treatment for Mood Disorders: A Systematic Review: Le cannabidiol comme traitement des troubles de l’humeur: une revue systématique

Jairo Vinícius Pinto, Gayatri Saraf, Christian Frysch, Daniel Vigo, Kamyar Keramatian, Trisha Chakrabarty, Raymond W. Lam, Márcia Kauer-Sant’Anna, Lakshmi N. Yatham

Can J Psychiatry. 2020 Apr; 65(4): 213–227. doi: 10.1177/0706743719895195

PMCID:: PMC7385425

Article PubReader PDF–410K Cite

Select item 89126623.

The Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective

Cielo García-Montero, Miguel A. Ortega, Miguel Angel Alvarez-Mon, Oscar Fraile-Martinez, Adoración Romero-Bazán, Guillermo Lahera, José Manuel Montes-Rodríguez, Rosa M. Molina-Ruiz, Fernando Mora, Roberto Rodriguez-Jimenez, Javier Quintero, Melchor Álvarez-Mon

Nutrients. 2022 Mar; 14(5): 1107. Published online 2022 Mar 6. doi: 10.3390/nu14051107

PMCID:: PMC8912662

Article PubReader PDF–2.1M Cite

Select item 82544544.

Cannabidiol prevents lipopolysaccharide-induced sickness behavior and alters cytokine and neurotrophic factor levels in the brain

Pedro Augusto Lopes Tito, Túlio Cézar de Souza Bernardino, Paula Maria Quaglio Bellozi, Maria Carolina Machado da Silva, Aline Silva de Miranda, Érica Leandro Marciano Vieira, Fabrício A. Moreira, András Palotás, Antônio Carlos Pinheiro de Oliveira, Helton José Reis

Pharmacol Rep. 2021; 73(6): 1680–1693. Published online 2021 Jul 3. doi: 10.1007/s43440-021-00301-8

PMCID:: PMC8254454

Article PubReader PDF–2.6M Cite

Select item 61616445.

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age

José A. Crippa, Francisco S. Guimarães, Alline C. Campos, Antonio W. Zuardi

Front Immunol. 2018; 9: 2009. Published online 2018 Sep 21. doi: 10.3389/fimmu.2018.02009

PMCID:: PMC6161644

Article PubReader PDF–1.1M Cite

Select item 97164906.

Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool

Caroline MB Kwee, Joop MA van Gerven, Fleur LP Bongaerts, Danielle C Cath, Gabriël Jacobs, Johanna MP Baas, Lucianne Groenink

J Psychopharmacol. 2022 Dec; 36(12): 1299–1314. Published online 2022 Oct 14. doi: 10.1177/02698811221124792

PMCID:: PMC9716490

Article PubReader PDF–1.4M Cite

Select item 75426107.

Treatment of social anxiety disorder and attenuated psychotic symptoms with cannabidiol

Maximus Berger, Emily Li, Günter Paul Amminger

BMJ Case Rep. 2020; 13(10): e235307. Published online 2020 Oct 7. doi: 10.1136/bcr-2020-235307

PMCID:: PMC7542610

Article PubReader PDF–178K Cite

Select item 91572448.

Cannabidiol and substance use disorder: dream or reality

Saeideh Karimi-Haghighi, Yasaman Razavi, Daniela Iezzi, Andrew F. Scheyer, Olivier Manzoni, Abbas Haghparast

Neuropharmacology. Author manuscript; available in PMC 2023 Apr 1.

Published in final edited form as: Neuropharmacology. 2022 Apr 1; 207: 108948. Published online 2022 Jan 13. doi: 10.1016/j.neuropharm.2022.108948

PMCID:: PMC9157244

Article PubReader PDF–528K Cite

Select item 94093119.

Cannabidiol Prevents Spontaneous Fear Recovery after Extinction and Ameliorates Stress-Induced Extinction Resistance

Eleni P. Papagianni, William G. Warren, Helen J. Cassaday, Carl W. Stevenson

Int J Mol Sci. 2022 Aug; 23(16): 9333. Published online 2022 Aug 19. doi: 10.3390/ijms23169333

PMCID:: PMC9409311

Article PubReader PDF–3.1M Cite

Select item 879952310.

A Scoping Review of the Use of Cannabidiol in Psychiatric Disorders

Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, Kevin M. Gray, Timothy E. Wilens, Lindsay M. Squeglia

Psychiatry Res. Author manuscript; available in PMC 2023 Feb 1.

Published in final edited form as: Psychiatry Res. 2022 Feb; 308: 114347. Published online 2021 Dec 20. doi: 10.1016/j.psychres.2021.114347

PMCID:: PMC8799523

Article PubReader PDF–380K Cite

Select item 874470611.

Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review

Danielle Hen-Shoval, Aron Weller, Abraham Weizman, Gal Shoval

Int J Environ Res Public Health. 2022 Jan; 19(1): 523. Published online 2022 Jan 4. doi: 10.3390/ijerph19010523

PMCID:: PMC8744706

Article PubReader PDF–955K Cite

Select item 776546312.

Subacute cannabidiol alters genome‐wide DNA methylation in adult mouse hippocampus

Nicole M Wanner, Mathia Colwell, Chelsea Drown, Christopher Faulk

Environ Mol Mutagen. Author manuscript; available in PMC 2021 Nov 1.

Published in final edited form as: Environ Mol Mutagen. 2020 Nov; 61(9): 890–900. Published online 2020 Aug 10. doi: 10.1002/em.22396

PMCID:: PMC7765463

Article PubReader PDF–676K Cite

Select item 969086813.

Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models

Luana B. Domingos, Nicole R. Silva, Adriano J. M. Chaves Filho, Amanda J. Sales, Anna Starnawska, Sâmia Joca

Genes (Basel) 2022 Nov; 13(11): 2165. Published online 2022 Nov 20. doi: 10.3390/genes13112165

PMCID:: PMC9690868

Article PubReader PDF–3.1M Cite

Select item 727755314.

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression

Zsolt Gáll, Szidónia Farkas, Ákos Albert, Elek Ferencz, Szende Vancea, Melinda Urkon, Melinda Kolcsár

Biomolecules. 2020 May; 10(5): 801. Published online 2020 May 22. doi: 10.3390/biom10050801

PMCID:: PMC7277553

Article PubReader PDF–1.9M Cite

Select item 755480315.

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease

Aleksandra Kicman, Marek Toczek

Int J Mol Sci. 2020 Sep; 21(18): 6740. Published online 2020 Sep 14. doi: 10.3390/ijms21186740

PMCID:: PMC7554803

Article PubReader PDF–2.4M Cite

Select item 995351816.

Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression

Uri Bright, Irit Akirav

Int J Mol Sci. 2023 Feb; 24(3): 2052. Published online 2023 Jan 20. doi: 10.3390/ijms24032052

PMCID:: PMC9953518

Article PubReader PDF–1.9M Cite

Select item 791775917.

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

Philippe A. Melas, Maria Scherma, Walter Fratta, Carlo Cifani, Paola Fadda

Int J Mol Sci. 2021 Feb; 22(4): 1863. Published online 2021 Feb 13. doi: 10.3390/ijms22041863

PMCID:: PMC7917759

Article PubReader PDF–334K Cite

Select item 581814718.

Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

Natalie E. Zlebnik, Joseph F. Cheer

Annu Rev Neurosci. Author manuscript; available in PMC 2018 Feb 19.

Published in final edited form as: Annu Rev Neurosci. 2016 Jul 8; 39: 1–17. Published online 2016 Feb 24. doi: 10.1146/annurev-neuro-070815-014038

PMCID:: PMC5818147

Article PubReader PDF–358K Cite

Select item 789121419.

Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?

Saoirse E. O'Sullivan, Carl W. Stevenson, Steven R. Laviolette

Cannabis Cannabinoid Res. February 2021; 6(1): 7–18. Published online 2021 Feb 12. doi: 10.1089/can.2020.0102

PMCID:: PMC7891214

Article PubReader PDF–216K Cite

Select item 1004885720.

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, Cristina Miliano

Int J Mol Sci. 2023 Mar; 24(6): 5251. Published online 2023 Mar 9. doi: 10.3390/ijms24065251

PMCID:: PMC10048857

Article PubReader PDF–2.3M Cite

<< First< Prev

Page of 250

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

PMC Images search for depression cannabidiol

Fig. (4)

Plant-derived terpenes against depression (52) Podoandin (53) Cannabidiol (54) Carvacrol (55) β-Caryophyllene (56) Genipin (57) Hyperforin (58) Salvinorin A (59) Ursolic acid.

Depression: An Insight into Heterocyclic and Cyclic Hydrocarbon Compounds Inspired from Natural Sources

Curr Neuropharmacol. 2021 Nov 15;19(11):2020-2037.
Figure 4

Results of the sucrose preference test for rats submitted to a four-week CUMS treatment with or without cannabidiol administration (mean ± SEM, n = 18). (A.) Sucrose preference measured as % preference for sucrose; (B.) sucrose (mL of 1.0% sucrose solution ingested) and water intake on each testing day. CBD, cannabidiol; * p < 0.05 vs baseline.

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression

Biomolecules. 2020 May;10(5):801.
Figure 3

Results of body weight measurements during a four-week CUMS procedure with or without concomitant cannabidiol (10 mg/kg body weight) treatment. Data are expressed as mean ± 95% confidence interval; * p < 0.05 vs. control.

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression

Biomolecules. 2020 May;10(5):801.
FIGURE 1

Results for Anxiety (A), depression (B), emotional exhaustion (C), and posttraumatic stress (D).

Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic

Front Pharmacol. 2022;13:856846.